Blog

 

 

FDA Approves New Drug that Slows the Spread of Alzheimer’s Disease

FDA Approves New Drug that Slows the Spread of Alzheimer’s Disease

Daniel Andrews / October 26, 2023
What is Alzheimer's Disease?    Alzheimer's is a devastating form of dementia that affects 6.5 million Americans, and 55 million people worldwide. The disease is the seventh-leading cause of death and one of the primary causes of disability in elderly...
Read More
Frenalytics Announces Contract with Joshua Independent School District

Frenalytics Announces Contract with Joshua Independent School District

Team Frenalytics / October 24, 2023
Frenalytics Announces Contract with Houston Independent School District

Frenalytics Announces Contract with Houston Independent School District

Team Frenalytics / October 11, 2023
Frenalytics Named Finalist in Coveted 2023 Supes’ Choice Awards by the Institute for Education Innovation

Frenalytics Named Finalist in Coveted 2023 Supes’ Choice Awards by the Institute for Education Innovation

Team Frenalytics / October 6, 2023
Frenalytics Announces Contract with Richardson Independent School District

Frenalytics Announces Contract with Richardson Independent School District

Team Frenalytics / September 28, 2023
Frenalytics Selected to Participate in EdTech Week’s ‘Shark Tank’ Competition

Frenalytics Selected to Participate in EdTech Week’s ‘Shark Tank’ Competition

Team Frenalytics / September 26, 2023
A Look Into Disability Treatment Worldwide

A Look Into Disability Treatment Worldwide

Daniel Andrews / September 5, 2023
Frenalytics Selected to Advance to Semi-Final Round of NSF’s VITAL Prize Challenge

Frenalytics Selected to Advance to Semi-Final Round of NSF’s VITAL Prize Challenge

Team Frenalytics / July 17, 2023
Frenalytics Wins Audience Favorite Award in 2Gether-International’s Spring Cohort Pitch Competition

Frenalytics Wins Audience Favorite Award in 2Gether-International’s Spring Cohort Pitch Competition

Team Frenalytics / May 26, 2023
Frenalytics Wins Stevie® Award for Achievement in User Interface Design

Frenalytics Wins Stevie® Award for Achievement in User Interface Design

Team Frenalytics / May 10, 2023
Frenalytics Accepted to NSF’s VITAL Prize Challenge

Frenalytics Accepted to NSF’s VITAL Prize Challenge

Team Frenalytics / April 26, 2023
FrenalyticsEDU Named ‘Cool Tool’ Finalist in 2023 EdTech Awards

FrenalyticsEDU Named ‘Cool Tool’ Finalist in 2023 EdTech Awards

Team Frenalytics / April 5, 2023
Frenalytics Named a Finalist for MassChallenge’s 2023 HealthTech Cohort

Frenalytics Named a Finalist for MassChallenge’s 2023 HealthTech Cohort

Team Frenalytics / March 21, 2023
Savant Syndrome: What Is It and How Is It Represented in the Media?

Savant Syndrome: What Is It and How Is It Represented in the Media?

Hailey Park / February 28, 2023
Frenalytics Featured on February 14th Episode of #nolimits Podcast by IEP Consultant Shelley Kenow

Frenalytics Featured on February 14th Episode of #nolimits Podcast by IEP Consultant Shelley Kenow

Team Frenalytics / February 23, 2023
Special Education Inner Circle Podcast Features Frenalytics in January 25 Episode on Collaborative IEP Data Collection at Home and School

Special Education Inner Circle Podcast Features Frenalytics in January 25 Episode on Collaborative IEP Data Collection at Home and School

Team Frenalytics / February 1, 2023
What Role Does Technology Play in Special Education?

What Role Does Technology Play in Special Education?

Hailey Park / January 24, 2023
Frenalytics and Molloy University Expand Partnership to Deliver Digital Healthcare Solutions to Long Island’s Underserved Populations

Frenalytics and Molloy University Expand Partnership to Deliver Digital Healthcare Solutions to Long Island’s Underserved Populations

Team Frenalytics / January 18, 2023
Frenalytics Named “Elite 200” Semifinalist in Preeminent 2023 GSV Cup

Frenalytics Named “Elite 200” Semifinalist in Preeminent 2023 GSV Cup

Team Frenalytics / January 4, 2023
Happy Holidays from Team Frenalytics!

Happy Holidays from Team Frenalytics!

Team Frenalytics / December 29, 2022
1 … 4 5 6 7 8 9

© 2026 Think Group Holdings LLC.